Intra-Cellular Therapies
ITCI
#1234
Rank
HK$109.19 B
Marketcap
HK$1,025
Share price
0.00%
Change (1 day)
94.51%
Change (1 year)

Revenue for Intra-Cellular Therapies (ITCI)

Revenue in 2024 (TTM): HK$5.30 Billion

According to Intra-Cellular Therapies's latest financial reports the company's current revenue (TTM ) is HK$5.28 Billion. an increase over the revenue in the year 2023 that were of HK$3.60 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intra-Cellular Therapies from 2014 to 2024

Annual revenue

Year Revenue Change
2024 HK$5.28 B46.36%
2023 HK$3.60 B85.44%
2022 HK$1.94 B205.52%
2021 HK$0.63 B264.77%
2020 HK$0.17 B36900.05%
2019 HK$0.47 M
2018 N/A
2017 N/A
2016 N/A-100%
2015 HK$0.23 M-94.4%
2014 HK$4.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$79.74 M-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.99 B-81.23%๐Ÿ‡บ๐Ÿ‡ธ USA